Parimer Scientific

Parimer partnered with Luna Labs USA to develop a sprayable hydrogel for post-surgical adhesion prevention, an evolution from their initial flat-sheet barrier film based on surgeon feedback. ?? How Parimer Helped: ?? Optimized formulation for solubility & sterilization ?? Ensured GMP-compliant manufacturing for preclinical testing ?? Supported FDA IDE & PMA processes Together, we're driving this innovation toward clinical trials and future enhancements. Read more about it here https://lnkd.in/g-6FYdEy

Scientist Spotlight: Stephen Lee ? Stephen Lee is a scientist at Parimer Scientific, known for his versatility and problem-solving skills. His work spans organic synthesis, where he develops new molecules, and chemical characterization, utilizing advanced techniques like NMR (nuclear magnetic resonance) to analyze and validate compounds. ? One of his most intriguing projects involved a potential chemotherapeutic drug, where he played a crucial role in troubleshooting and refining a key purification step—an intricate challenge that demanded both analytical precision and patience. ? What drives Stephen? He values client satisfaction and mentorship, finding fulfillment in guiding younger scientists and helping them navigate an often complex and demanding industry. ? Beyond the lab, Stephen is a strong communicator, seamlessly balancing hands-on chemistry with project management and client interactions.? ? Stephen’s career has been shaped by adaptability, curiosity, and a relentless drive to solve complex scientific challenges—one experiment at a time.

Bringing a drug to market can be complex, but Parimer Scientific makes it easier. As a U.S.-based drug development company, we specialize in: ?? Reverse Engineering for FDA Compliance ?? Small-Batch Production ?? Rare Disease Drug Development We help solve complex challenges - https://lnkd.in/gq9djysW

Advancing Parkinson’s Research Parimer partnered with THE MICHAEL J FOX FOUNDATION FOR PARKINSON to restore a critical reagent for imaging tracer development which is essential for early Parkinson’s detection. With reverse engineering and small-batch manufacturing, we’ve developed a promising prototype to support researchers in their vital work. Read more - - https://lnkd.in/g6X_Gde9

The journey of drug innovation in the U.S. is complex, expensive, and often decades long. In our latest blog, we dive into: - The role of universities in early-stage innovation - How patents attract investment and partnerships - Why drug development costs so much—and how Parimer helps simplify the process Discover how Parimer is streamlining drug innovation to bring therapies to patients faster and more affordably. https://lnkd.in/gNEdK6eM

In a fast-evolving pharmaceutical industry, innovation and collaboration are key to staying ahead. At Parimer, our focus is combining advanced research with practical solutions to create a good product. Some ways that we do this is through: ?? Driving R&D Forward: From designing new compounds and polymers to developing innovative drug delivery systems, our work helps address complex challenges in drug development. ?? Commitment to Improvement: Enhancing existing drugs and refining manufacturing processes are central to our efforts to help partners improve efficiency and meet industry demands. ?? A Transparent Approach to Patents: Our intellectual property policies allow partners to retain ownership of their innovations, fostering trust and enabling unrestricted commercialization. ?? Connecting Research to Application: With advanced facilities and expertise, we can help bridge the gap between lab research and market-ready solutions, offering support for a range of pharmaceutical needs. ?? Collaborative Partnerships: By working closely with academia, startups, and industry leaders, we aim to contribute to meaningful advancements in drug development. Read more about how our approach - https://lnkd.in/gz39Y3XZ

Soon, world leaders in the pharma development community will gather in Milan to discuss the future of healthcare, drug innovation, and the impact of the recently passed BIOsecure Act. As a domestic contractor for drug development, we are eager to see what changes this act has on the pharma innovation market, as a whole. Discussions of EU pharma security will likely be a hot topic with this recent American legislation. ? Parimer was a proud exhibitor at CPHI North America, but will unfortunately miss the European conference. If you are looking for an API development partner (Parimer or otherwise), I would encourage you to connect with our colleague Vincent (Vinnie) Ursino Jr. who will be present with many US and EU API development connections.? #CPHIMILAN #CPHIGLOBAL

So proud to be a part of the Parimer team!

It was great connecting with so many great people and industry leaders at CPHI last week in Philly! Looking forward to continuing these conversations over the coming weeks. #CPhINA #CPhINorthAmerica #CDMO #Pharma

To all the mothers who are involved in and have helped make life sciences possible, thank you and we hope you had a happy Mother’s Day yesterday!